CN121471129A - 用于标记肿瘤组织的新型荧光化合物 - Google Patents

用于标记肿瘤组织的新型荧光化合物

Info

Publication number
CN121471129A
CN121471129A CN202511568024.1A CN202511568024A CN121471129A CN 121471129 A CN121471129 A CN 121471129A CN 202511568024 A CN202511568024 A CN 202511568024A CN 121471129 A CN121471129 A CN 121471129A
Authority
CN
China
Prior art keywords
chemical formula
compounds
compound
tumor
tumor tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202511568024.1A
Other languages
English (en)
Chinese (zh)
Inventor
J·特兰-古永
V·古永
F·舍宁斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promakinger
Original Assignee
Promakinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promakinger filed Critical Promakinger
Publication of CN121471129A publication Critical patent/CN121471129A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202511568024.1A 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物 Pending CN121471129A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR2004868A FR3110165B1 (fr) 2020-05-15 2020-05-15 Nouveaux composés fluorescents pour le marquage de tissu tumoral
FRFR2004868 2020-05-15
PCT/FR2021/050832 WO2021229188A1 (fr) 2020-05-15 2021-05-12 Nouveaux composés fluorescents pour le marquage de tissu tumoral
CN202180035401.9A CN115605459A (zh) 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202180035401.9A Division CN115605459A (zh) 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物

Publications (1)

Publication Number Publication Date
CN121471129A true CN121471129A (zh) 2026-02-06

Family

ID=72644317

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202511568024.1A Pending CN121471129A (zh) 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物
CN202180035401.9A Pending CN115605459A (zh) 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202180035401.9A Pending CN115605459A (zh) 2020-05-15 2021-05-12 用于标记肿瘤组织的新型荧光化合物

Country Status (9)

Country Link
US (1) US20230203014A1 (enExample)
EP (1) EP4149925A1 (enExample)
JP (2) JP7864694B2 (enExample)
KR (1) KR102991654B1 (enExample)
CN (2) CN121471129A (enExample)
BR (1) BR112022023154A2 (enExample)
CA (1) CA3178232A1 (enExample)
FR (1) FR3110165B1 (enExample)
WO (1) WO2021229188A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3248903A1 (en) * 2022-02-02 2023-08-10 Vergent Bioscience, Inc. METHODS FOR LOCALIZING CANCER TISSUE USING A FLUORESCENT MOLECULAR IMAGING AGENT FOR DIAGNOSIS OR TREATMENT
CN114751907A (zh) * 2022-03-17 2022-07-15 南京诺源医疗器械有限公司 一种主动靶向叶酸受体近红外荧光分子及其制备方法和用途
CN116947829B (zh) * 2023-07-05 2025-09-23 上海内瑟汐医疗科技有限公司 一种基于新吲哚菁绿ir820的荧光化合物及其制备和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06145539A (ja) * 1992-11-04 1994-05-24 Fuji Photo Film Co Ltd シアニン化合物
JPH07287346A (ja) * 1994-04-08 1995-10-31 E I Du Pont De Nemours & Co 近赤外ハレーション防止用の新規なエーテル色素を有する写真エレメント
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
JP2005220045A (ja) * 2004-02-04 2005-08-18 Konica Minolta Medical & Graphic Inc 蛍光造影剤
EP2100621A1 (en) 2008-03-10 2009-09-16 mivenion GmbH Polyether polyol dendron conjugates with effector molecules for biological targeting
EP2552825A4 (en) * 2010-03-01 2014-03-12 Univ Florida NIR-MATERIALS AND -NANOMATERIALS FOR THEROSTATIC APPLICATIONS
CN102268191B (zh) * 2010-06-06 2013-08-14 史春梦 七甲川吲哚花菁染料及其合成方法和应用
CN103911017B (zh) * 2012-12-28 2017-09-15 浙江海正药业股份有限公司 菁染料化合物及其制备方法、用于光动力学疗法的双重功能剂及其制备方法
CN105693590B (zh) * 2016-01-15 2019-01-15 复旦大学 一种pH控制识别肿瘤细胞的光热试剂及其制备方法和应用
KR101980292B1 (ko) * 2017-08-03 2019-05-20 (주)바이오액츠 형광 화합물 및 이의 제조방법
EP3517146A1 (en) * 2018-01-26 2019-07-31 Université de Strasbourg Fluorescent polymeric coating film for medical devices

Also Published As

Publication number Publication date
BR112022023154A2 (pt) 2023-02-07
EP4149925A1 (fr) 2023-03-22
JP7864694B2 (ja) 2026-05-25
CA3178232A1 (fr) 2021-11-18
CN115605459A (zh) 2023-01-13
KR102991654B1 (ko) 2026-07-15
FR3110165A1 (fr) 2021-11-19
KR20230010713A (ko) 2023-01-19
WO2021229188A1 (fr) 2021-11-18
FR3110165B1 (fr) 2022-10-28
JP2023525601A (ja) 2023-06-16
US20230203014A1 (en) 2023-06-29
JP2026042845A (ja) 2026-03-11

Similar Documents

Publication Publication Date Title
JP6006271B2 (ja) 蛍光リン脂質エーテル化合物、組成物、及びその使用
CN105339436B (zh) 4,4-二取代环己基桥连七甲川花菁染料及其应用
JP7308366B2 (ja) アクティブターゲティング型葉酸受容体近赤外蛍光分子及びその調製方法
JP2026042845A (ja) 腫瘍組織を標識するための新規蛍光化合物
CN111362971B (zh) 靶向psma的双苯并噻二唑类化合物及其制备方法与应用
CN114377152B (zh) 一种生物标志物响应型荧光示踪剂及其制备方法和应用
CN110746410A (zh) 一种亮氨酸氨肽酶和单胺氧化酶激活的近红外荧光探针、合成方法及生物应用
WO2010074326A1 (en) Probe for a biological specimen and labelling method and screening method using the probe
US11964965B2 (en) Methods of manufacture and synthesis of fluorescent dye compounds and uses thereof
CN118955509A (zh) 一种靶向近红外荧光化合物及其制备方法和应用
US8916137B2 (en) Monofunctional carbocyanine dyes for in vivo and in vitro imaging
US20260061080A1 (en) Fluorescent compound based on new indocyanine green ir820, and preparation and use thereof
CN110066243A (zh) 荧光性喹啉衍生物、其制备方法、组合物和用途
JP2010203966A (ja) 低酸素領域イメージング用近赤外蛍光プローブ
RU2847417C1 (ru) Новые флуоресцентные соединения для введения метки в опухолевую ткань
CN115746074B (zh) 一种PSCA特异性结合的近红外探针GGa-ICG的合成方法及应用
CN115337409B (zh) 白蛋白结合型近红外荧光探针-脂肪酸共轭物及其制备方法和应用
CN116284028A (zh) 一种特异性靶向脂筏荧光探针及其制备方法和应用
CN108250125B (zh) 一种肿瘤靶向探针化合物及其合成和应用
CN120025318B (zh) 近红外二区花菁类荧光有机分子、荧光靶向分子探针及其制备方法与应用
HK40096921A (en) Contrast imaging composition for cancer
CN119798132A (zh) 一种靶向psma的荧光二聚体探针及其药用盐和应用
WO2022202863A1 (ja) がん造影用組成物
CN120923435A (zh) 一种新型肝胆特异性造影剂
CN107739528A (zh) 一种五肽改性菁染料化合物及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination